Infuse Open-Access Project A Model For The Future? Medtronic Thinks So
This article was originally published in The Pink Sheet Daily
Executive Summary
Two independent analyses published on Medtronic’s Infuse biologic bone graft do not paint a positive picture for the device, but they do represent an important model for the future of open-access data analysis for drugs and devices, both Medtronic and academic proponents say.